Interojo Co

Interojo Co CapEx/OCF

The CapEx to Operating Cash Flow Ratio of Interojo Co (119610.KQ) as of Nov 20, 2026 is 27.33 %. In the previous year, CapEx to Operating Cash Flow Ratio was 16.73 % — a change of 63.40% (higher).

CapEx/OCF

27.33 %

YoY

63.40%

Last updated:

CapEx to Operating Cash Flow Ratio of Interojo Co is 2025 27.33 % . CapEx to Operating Cash Flow Ratio of Interojo Co was 2024 16.73 % . It decreases by 63.40% higher compared to the previous year.

The Interojo Co CapEx/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/OCF
Date
CapEx/OCF
Jan 1, 2018
144.24 KRW
Jan 1, 2019
67.52 KRW
Jan 1, 2020
155.61 KRW
Jan 1, 2021
77.39 KRW
Jan 1, 2022
142.17 KRW
Jan 1, 2023
99.15 KRW
Jan 1, 2024
16.73 KRW
Jan 1, 2025
27.33 KRW
The Interojo Co CapEx/OCF history
YEARCapEx/OCFYoY
27.33 %+63.40%
16.73 %-83.13%
99.15 %-30.26%
142.17 %+83.70%
77.39 %-50.26%
155.61 %+130.46%
67.52 %-53.19%
144.24 %+196.99%
48.57 %+50.13%
32.35 %-39.55%
53.52 %-5.54%
56.66 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Interojo Co Stock analysis

What does Interojo Co do? Interojo Co Ltd manufactures and sells contact lenses including silicone hydrogel lenses, sodium hyaluronate lenses, frequent replacement lenses, conventional lenses, toric lenses, multifocal vision lenses, color lenses, therapy and bandage lenses, and rigid gas permeable (RGP) contact lenses along with solutions. The company distributes its products in domestic and overseas markets, targeting both retail consumers and healthcare providers who purchase lenses for patient use. Its product range caters to diverse vision correction needs, from standard to specialized medical applications, with solutions supporting lens care and usage. The firm's primary revenue streams come from the sale of contact lenses and associated solutions to customers in both domestic and international markets. Products like silicone hydrogel lenses and RGP contact lenses represent key offerings for everyday wear and specialized vision correction, while therapy and bandage lenses serve medical applications requiring professional oversight. The company's domestic market presence complements its overseas distribution, ensuring broad accessibility across different customer segments. Interojo Co Ltd's business model focuses on direct sales of its comprehensive product portfolio to end-users and healthcare institutions. The company's product lines address various vision correction scenarios, from routine daily use with frequent replacement lenses to advanced medical needs with therapy lenses. By maintaining a diverse range of contact lenses and solutions, the company serves both consumer and professional markets without relying on third-party partnerships or additional services. Interojo Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Interojo Co stock

CapEx to Operating Cash Flow Ratio of Interojo Co is 27.33 % in 2025.

CapEx to Operating Cash Flow Ratio of Interojo Co changed from 16.73 % to 27.33 %, representing a 63.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Operating Cash Flow Ratio Interojo Co since 2006 – with annual values, charts, and detailed analysis.

The CapEx/OCF ratio shows what percentage of operating cash flow is reinvested in capital assets. Lower ratios indicate more free cash available for shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Operating Cash Flow Ratio's Interojo Co with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Operating Cash Flow Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Operating Cash Flow Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Interojo Co

All Key Metrics — Interojo Co